v3.25.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
Schedule of Percentage of Revenue and Accounts Receivable from Customers Multiple customers have provided more than 10% of total revenue in the periods presented, or accounted for more than 10% of accounts receivable at each respective balance sheet date, as follows:

 

 

Revenue

 

Accounts Receivable

 

 

Three Months Ended March 31,

 

March 31, 2025

 

December 31, 2024

 

 

2025

 

2024

 

 

 

 

Moderna, Inc.

 

27%

 

24%

 

14%

 

*

VA MVP

 

20%

 

*

 

11%

 

*

Pfizer Inc.

 

*

 

*

 

26%

 

25%

Merck & Co., Inc.

 

*

 

*

 

*

 

31%

Natera, Inc.

 

12%

 

41%

 

*

 

13%

AstraZeneca UK Limited

 

*

 

*

 

18%

 

*

* Less than 10% of revenue or accounts receivable